Full Text
PSS29 Real-World Characteristics and Severity Assessment of United States Health Plan Members Treated with Ustekinumab for Moderate-to-Severe Psoriasis

Abstract

Authors

C. Carter Q. Cai A. AbuDagga M. Jones H. Tan S. Martin

Back to Volume 15, Issue 4
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×